Literature DB >> 21586415

Low-carbohydrate diet review: shifting the paradigm.

Adele H Hite1, Valerie Goldstein Berkowitz, Keith Berkowitz.   

Abstract

What does a clinician need to know about low-carbohydrate (LC) diets? This review examines and compares the safety and the effectiveness of a LC approach as an alternative to a low-fat (LF), high-carbohydrate diet, the current standard for weight loss and/or chronic disease prevention. In short-term and long-term comparison studies, ad libitum and isocaloric therapeutic diets with varying degrees of carbohydrate restriction perform as well as or better than comparable LF diets with regard to weight loss, lipid levels, glucose and insulin response, blood pressure, and other important cardiovascular risk markers in both normal subjects and those with metabolic and other health-related disorders. The metabolic, hormonal, and appetite signaling effects of carbohydrate reduction suggest an underlying scientific basis for considering it as an alternative approach to LF, high-carbohydrate recommendations in addressing overweight/obesity and chronic disease in America. It is time to embrace LC diets as a viable option to aid in reversing diabetes mellitus, risk factors for heart disease, and the epidemic of obesity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21586415     DOI: 10.1177/0884533611405791

Source DB:  PubMed          Journal:  Nutr Clin Pract        ISSN: 0884-5336            Impact factor:   3.080


  31 in total

Review 1.  Cannabimimetic phytochemicals in the diet - an evolutionary link to food selection and metabolic stress adaptation?

Authors:  Jürg Gertsch
Journal:  Br J Pharmacol       Date:  2017-01-16       Impact factor: 8.739

Review 2.  Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma.

Authors:  Angela Poff; Andrew P Koutnik; Kathleen M Egan; Solmaz Sahebjam; Dominic D'Agostino; Nagi B Kumar
Journal:  Semin Cancer Biol       Date:  2017-12-30       Impact factor: 15.707

Review 3.  Nutrient restriction and radiation therapy for cancer treatment: when less is more.

Authors:  Colin E Champ; Renato Baserga; Mark V Mishra; Lianjin Jin; Federica Sotgia; Michael P Lisanti; Richard G Pestell; Adam P Dicker; Nicole L Simone
Journal:  Oncologist       Date:  2013-01-08

4.  Metabolic Correction in Patients Sample with Diabetes: Clinical Outcomes and Costs Reductions.

Authors:  Jorge R Miranda-Massari; José R Rodríguez-Gómez; Michael J González; Carlos Cidre; Jorge Duconge; Heriberto Marín; Kazuko Grace; Howard L McLeod
Journal:  Int J Diabetes Res       Date:  2016

5.  Weight gain, metabolic syndrome, and breast cancer recurrence: are dietary recommendations supported by the data?

Authors:  Colin E Champ; Jeff S Volek; Joshua Siglin; Lianjin Jin; Nicole L Simone
Journal:  Int J Breast Cancer       Date:  2012-09-24

6.  Comparison with ancestral diets suggests dense acellular carbohydrates promote an inflammatory microbiota, and may be the primary dietary cause of leptin resistance and obesity.

Authors:  Ian Spreadbury
Journal:  Diabetes Metab Syndr Obes       Date:  2012-07-06       Impact factor: 3.168

7.  Supporting people to implement a reduced carbohydrate diet: a qualitative study in family practice.

Authors:  Caroline Cupit; Emma Redman
Journal:  BMJ Nutr Prev Health       Date:  2021-05-10

8.  Behavioral interventions for antipsychotic induced appetite changes.

Authors:  Ursula Werneke; David Taylor; Thomas A B Sanders
Journal:  Curr Psychiatry Rep       Date:  2013-03       Impact factor: 5.285

9.  Gastric electrical stimulation for the treatment of obesity: from entrainment to bezoars-a functional review.

Authors:  Martin P Mintchev
Journal:  ISRN Gastroenterol       Date:  2013-02-07

10.  Concerted suppression of all starch branching enzyme genes in barley produces amylose-only starch granules.

Authors:  Massimiliano Carciofi; Andreas Blennow; Susanne L Jensen; Shahnoor S Shaik; Anette Henriksen; Alain Buléon; Preben B Holm; Kim H Hebelstrup
Journal:  BMC Plant Biol       Date:  2012-11-21       Impact factor: 4.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.